Pasithea Therapeutics Corp. (KTTAW)

NASDAQ • Currency in USD

$85.00

-$0.88

-1.02%

Last Update: 18 Jul 2026, 12:54

$597.64m

Market Cap

-40.87

P/E Ratio (TTM)

—

Forward Dividend Yield

$62.38-$113.30

52 Week Range

KTTAW Stock Price Chart

Explore Pasithea Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze KTTAW price movements and trends.

KTTAW Company Profile

Discover essential business fundamentals and corporate details for Pasithea Therapeutics Corp. (KTTAW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

15 Sept 2021

Employees

4.00

Website

http://pasitheaclinics.com

CEO

Tiago Reis Marques

Description

Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression. At these facilities, certified pharmacists will administer intravenous ketamine infusions, and the firm will also extend business support services for these operations. Founded in 2020, Pasithea Therapeutics Corp. maintains its corporate headquarters in Miami Beach, Florida.

KTTAW Financial Timeline

Browse a chronological timeline of Pasithea Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 2 Sept 2026

EPS estimate is -$0.16, while revenue estimate is $300.00k.

Earnings released on 3 Jun 2026

Earnings released on 15 May 2026

EPS came in at -$0.12 matching the estimated -$0.12.

Earnings released on 30 Mar 2026

EPS came in at -$0.79 falling short of the estimated -$0.18 by -338.89%.

Earnings released on 25 Feb 2026

EPS came in at -$0.18 matching the estimated -$0.18.

Earnings released on 13 Nov 2025

EPS came in at -$408.04 .

Earnings released on 14 Aug 2025

EPS came in at -$0.66 .

Earnings released on 15 May 2025

EPS came in at -$1.61 .

Earnings released on 30 Sept 2023

EPS came in at -$0.00 .

Earnings released on 30 Jun 2023

EPS came in at -$0.14 .

Earnings released on 31 Mar 2023

EPS came in at -$10.55 .

Earnings released on 31 Dec 2022

EPS came in at -$0.15 , while revenue for the quarter reached $240.71k .

KTTAW Stock Performance

Access detailed KTTAW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.